Results 1-3 of 3 for drugs segment:8857351

An Bille um an Aonú Leasú is Daichead ar an mBunreacht (An Comhaontú maidir le Cúirt Aontaithe um Paitinní), 2024: Céim an Choiste agus na Céimeanna a bheidh Fágtha - Forty-first Amendment of the Constitution (Agreement on a Unified Patent Court) Bill 2024: Committee and Remaining Stages (6 Mar 2024)

Neale Richmond: ...course one reason for the delay was the UK's decision to withdraw from the European Union and, therefore, withdraw from the formulation of this court. As it stands, if a piece of technology or a drug is developed with cross-Border co-operation, it is registered for a patent in the jurisdiction where it is registered. The patent can be registered, if it is in Northern Ireland, with the...

An Bille um an Aonú Leasú is Daichead ar an mBunreacht (An Comhaontú maidir le Cúirt Aontaithe um Paitinní), 2024: Céim an Choiste agus na Céimeanna a bheidh Fágtha - Forty-first Amendment of the Constitution (Agreement on a Unified Patent Court) Bill 2024: Committee and Remaining Stages (6 Mar 2024)

Neale Richmond: ...quite clearly to its workers how important the referendum is to their jobs and how important it will be to existing and future patients, particularly given that the company does so much work on orphan drugs, which the Deputy mentioned. The referendum is a big undertaking. Holding it on the same day as the European elections is good as it will increase the turnout. When people are...

An Bille um an Aonú Leasú is Daichead ar an mBunreacht (An Comhaontú maidir le Cúirt Aontaithe um Paitinní), 2024: Céim an Choiste agus na Céimeanna a bheidh Fágtha - Forty-first Amendment of the Constitution (Agreement on a Unified Patent Court) Bill 2024: Committee and Remaining Stages (6 Mar 2024)

Denis Naughten: ...had a debate on rare diseases. Last Thursday, we had the Second Stage debate on this Bill, which was very timely. The provisions before us have huge implications for the development of orphan drugs, not just in this country but across Europe and globally. It is hoped that having a unified patent system in Europe will ensure more investment goes into the development of orphan drugs and...